Overall Technical outlook

Price Summary

NATCO Pharma Limited's stock opened at 1093.65 on 2026-04-30, surged to 1106.95, hit a low of 1087.0, and closed up 0.19% at 1095.75, with 387663 shares traded.
The highest price the stock achieved in the past 52 weeks is 1123.7, while the lowest price it saw is 792.95.
Analysts expect the price of NATCOPHARM to vary between 712.0 and 1180.0, with an average expected price near 938.1.

Technicals

Support and Resistance: The current price of 1095.75 for NATCOPHARM finds support at 1016.15 and resistance at 1100.05. These levels define a range in which the price might oscillate, with 1016.15 as a potential support and 1100.05 as a resistance level.
NATCOPHARM supportResistance e9271a
Support/Resistance for NATCOPHARM


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
NATCOPHARM aroon e9271a
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
NATCOPHARM bbands e9271a
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM continues to signal a bearish stance, reinforcing a resistance level that could restrict upward movement. This resistance suggests that the market may remain under bearish pressure, with limited potential for breaking higher.
NATCOPHARM psar e9271a
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
NATCOPHARM stoch e9271a
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned in a bearish pattern, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, suggesting that the bearish momentum may be weakening. This could be an early sign of a potential bullish reversal for NATCOPHARM, as the market's downward trajectory begins to lose strength and a possible shift towards more positive price action may occur soon.
NATCOPHARM trippleSMA e9271a
Tripple SMA chart for NATCO Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.